{
    "nct_id": "NCT06511401",
    "official_title": "C-PAIN: Catalyzing Pharmacogenomic Analysis for Informing Pain Treatment",
    "inclusion_criteria": "* Persons receiving ongoing oncology care at the University of Chicago Medical Center for whom near-future pain opioid pain medication therapy is anticipated\n* Subjects must be at least 18 years of age.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Subjects taking an opioid at the time of enrollment, or within the past 30 days\n* Subjects who are currently undergoing palliative radiation\n* Subjects who have undergone, or are being actively considered for, bone marrow, liver or kidney transplantation.\n* Subjects with a history of or active blood cancer (e.g., leukemia).\n* Chronic kidney disease, as defined by Glomerular filtration rate (GFR) < 30/mL/min/1.73m2, due to the risk of decreased drug excretion.\n* Liver dysfunction, as defined by the following laboratory values, due to the risk of decreased drug metabolism: Total bilirubin greater than or equal to1.5 mg/dL, Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) greater than or equal to 2.5 X upper limit of normal*. (*Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT)  greater than or equal to 5 X upper limit of normal if hepatic metastases are present).\n* Inability to understand and give informed consent to participate in the opinion of the investigator\n* Subjects who are known to be pregnant at the time of enrollment\n* Subjects who are enrolled in other Pharmacogenomic (PGx) studies",
    "miscellaneous_criteria": ""
}